Spinocerebellar ataxia type 7 (SCA7):: a neurodegenerative disorder with neuronal intranuclear inclusions

被引:262
|
作者
Holmberg, M
Duyckaerts, C
Dürr, A
Cancel, G
Gourfinkel-An, I
Damier, P
Faucheux, B
Trottier, Y
Hirsch, EC
Agid, Y
Brice, A
机构
[1] Hop Salpetriere, INSERM, U289, F-75651 Paris 13, France
[2] Hop Salpetriere, Lab Neuropathol R Escourolle, F-75651 Paris, France
[3] Hop Salpetriere, Federat Neurol, F-75651 Paris 13, France
[4] Hop Salpetriere, Ctr Invest Clin, F-75651 Paris 13, France
[5] ULP, CNRS, INSERM, IGBMC, F-67404 Illkirch Graffenstaden, France
基金
英国医学研究理事会;
关键词
D O I
10.1093/hmg/7.5.913
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autosomal dominant cerebellar ataxia with progressive macular degeneration is caused by a CAG/glutamine repeat expansion in the SCA7 gene/protein. Neuronal intranuclear inclusions were detected in the brain of an early onset SCA7 case with the 1C2 antibody directed against an expanded polyglutamine domain. Nuclear inclusions were most frequent in the inferior olivary complex, a site of severe neuronal loss in SCA7. They were also observed in other brain regions, including the cerebral cortex, not considered to be affected in the disease. Using confocal microscopy we showed that some inclusions were ubiquitinated, but to varying degrees, ranging from <1% in the cerebral cortex to 60% in the inferior olive. In addition, we also observed cytoplasmic staining using the 1C2 antibody, particularly in the supramarginal gyrus, the hippocampus, the thalamus, the lateral geniculate body and the pontine nuclei. These data confirm that the presence of intranuclear inclusions in neurons is a common characteristic of disorders caused by CAG/polyglutamine expansions, but unlike what has been reported for Huntington's disease, SCA1 and SCA3/MJD, in SCA7 the inclusions were not restricted to the sites of severe neuronal loss.
引用
收藏
页码:913 / 918
页数:6
相关论文
共 50 条
  • [31] Retinal degeneration in spinocerebellar ataxia type7 (SCA7). Effect of CAG repeat length on the clinical manifestation.
    Sandgren, O
    Forsgren, L
    Holmberg, M
    Holmgren, G
    Johansson, J
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S193 - S193
  • [32] Trinucleotide expansions in the SCA7 gene in a large family with spinocerebellar ataxia and craniocervical dystonia
    Lin, Yan
    Zheng, Jia-Yong
    Jin, Yan-Hui
    Xie, Yan-Chen
    Jin, Zi-Bing
    [J]. NEUROSCIENCE LETTERS, 2008, 434 (02) : 230 - 233
  • [33] Neurodegenerative diseases: The spinocerebellar ataxia type 7 in Mexico
    Garcia-Martinez, Rolando
    Hernandez, Elizabeth
    Toledo, Rebeca
    Hernandez, Oscar H.
    Elena Hernandez, Maria
    Garcia, Luis I.
    Ortiz, Shirley
    Manzo, Jorge
    [J]. ENEUROBIOLOGIA, 2013, 4 (08):
  • [34] Expanded CAG repeats in Swedish spinocerebellar ataxia type 7 (SCA7) patients: effect of CAG repeat length on the clinical manifestation
    Johansson, J
    Forsgren, L
    Sandgren, O
    Brice, A
    Holmgren, G
    Holmberg, M
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (02) : 171 - 176
  • [35] Spinocerebellar ataxia 7 (SCA7) in Indian population: predilection of ATXN7-CAG expansion mutation in an ethnic population
    Faruq, Mohammed
    Srivastava, Achal Kumar
    Singh, Suman
    Gupta, Rohit
    Dada, Tanuj
    Garg, Ajay
    Behari, Madhuri
    Mukerji, Mitali
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 141 : 187 - 198
  • [36] Use of a home-based telerehabilitation platform for motor and cognitive treatment of a progressive spinocerebellar ataxia type 7 (SCA7): A case report
    Izquierdo, Ruth
    del Barco, Alberto
    Ferreiro, Tatiana
    Blasco, Sonia
    Gagliardo, Pablo
    Penades, Vicente
    Chirivella, Javier
    [J]. BRAIN INJURY, 2014, 28 (5-6) : 799 - 799
  • [37] Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study
    Koyano, S
    Uchihara, T
    Fujigasaki, H
    Nakamura, A
    Yagishita, S
    Iwabuchi, K
    [J]. NEUROSCIENCE LETTERS, 1999, 273 (02) : 117 - 120
  • [38] Spinocerebellar ataxia type 7 (SCA7):: First report of a systematic neuropathological study of the brain of a patient with a very short expanded CAG-repeat
    Rüb, U
    Brunt, ER
    Gierga, K
    Seidel, K
    Schultz, C
    Schöls, L
    Auburger, G
    Heinsen, H
    Ippel, PF
    Glimmerveen, WF
    Wittebol-Post, D
    Arai, K
    Deller, T
    Rai, D
    [J]. BRAIN PATHOLOGY, 2005, 15 (04) : 287 - 295
  • [39] Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3
    Evert, B. O.
    Schelhaas, J.
    Fleischer, H.
    de Vos, R. A. I.
    Brunt, E. R.
    Stenzel, W.
    Klockgether, T.
    Wuellner, U.
    [J]. CLINICAL NEUROPATHOLOGY, 2006, 25 (06) : 272 - 281
  • [40] Spinocerebellar Ataxia Type 7 (SCA7): A 13-Year Longitudinal Study of Clinical Course, Neuropathological Features, and Phenotype-Genotype Correlations
    Horton, Laura C.
    Frosch, Matthew P.
    Schmahmann, Jeremy D.
    [J]. NEUROLOGY, 2011, 76 (09) : A350 - A350